| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
transcription factor 4 | 0.464 | 0.846 | 1.00 |
|
disease | 0.100 | None | 1.000 | 2 | 1 | 2011 | 2014 | ||||||||
|
desert hedgehog signaling molecule | 0.650 | 0.423 | 0.22 |
|
disease | 0.100 | None | 1.000 | 1 | 2 | 2018 | 2018 | ||||||||
|
ABL proto-oncogene 1, non-receptor tyrosine kinase | 0.432 | 0.923 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
lysine acetyltransferase 6B | 0.525 | 0.731 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 2 | 2016 | 2016 | ||||||||
|
structural maintenance of chromosomes flexible hinge domain containing 1 | 0.631 | 0.615 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
BR serine/threonine kinase 2 | 0.700 | 0.500 | 0.95 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
nuclear receptor binding SET domain protein 1 | 0.505 | 0.769 | 1.00 |
|
disease | 0.100 | None | 0 | 2 | |||||||||||
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1 | 0.434 | 0.846 | 1.00 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
steroid 5 alpha-reductase 2 | 0.564 | 0.615 |
|
disease | 0.100 | None | 0 | 1 | ||||||||||||
|
AT-rich interaction domain 1B | 0.503 | 0.846 | 1.00 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
myelin regulatory factor | 0.584 | 0.731 | 1.00 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
transmembrane protein 258 | 0.644 | 0.654 | 1.9E-03 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
tubulin alpha 1a | 0.597 | 0.769 | 0.97 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
THO complex 6 | 0.705 | 0.577 | 4.8E-04 |
|
disease | 0.100 | None | 0 | 2 | |||||||||||
|
partner and localizer of BRCA2 | 0.485 | 0.769 | 3.0E-19 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
Fraser extracellular matrix complex subunit 1 | 0.560 | 0.577 | 3.1E-45 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
protein kinase cAMP-dependent type I regulatory subunit alpha | 0.401 | 0.846 | 1.00 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
pleckstrin homology domain interacting protein | 0.595 | 0.769 | 1.00 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
collagen type VI alpha 1 chain | 0.587 | 0.731 | 1.00 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
EBF transcription factor 3 | 0.595 | 0.731 | 1.00 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
NIPBL cohesin loading factor | 0.521 | 0.808 | 1.00 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
ankyrin repeat domain 11 | 0.556 | 0.808 | 1.00 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
FRAS1 related extracellular matrix 2 | 0.566 | 0.577 | 3.6E-11 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
fibroblast growth factor 14 | 0.619 | 0.692 | 0.91 |
|
disease | 0.100 | None | 0 | 1 |